Health · Pharma & Biotech · 6 hrs ago
GP warns weight-loss drugs can reduce muscle without proper support
A GP in western Sydney described serious muscle loss in a patient taking a GLP-1 weight-loss drug without follow-up from the provider who prescribed it.
The woman, who was over 60, struggled to rise from a chair.
A body scan found she had lost 10kg of muscle and gained 1kg of fat, putting her at significant risk of falls.
GLP-1 drugs such as Wegovy and Ozempic can help people lose weight and reduce some health risks when used with diet and exercise.
But too little food and protein can lead to malnutrition and muscle loss, the GP warned.
Many people regain weight after they stop taking the drugs, and some health benefits can also reverse.
The GP says patients need monitoring and support with nutrition and exercise, including a plan for when treatment ends.
A Sydney GP warns that weight-loss drugs can reduce muscle and cause other harms when patients do not receive proper follow-up and diet and exercise support.
One patient over 60 lost 10 kilograms of muscle and gained one kilogram of fat after taking a GLP-1 drug without follow-up or advice on diet and exercise.
The GP says muscle loss can increase the risk of falls, while stopping the drugs can lead to rapid weight regain.
He says GLP-1 medicines can produce good results when paired with nutritional and exercise support.
Modelling cited in the article projects that up to 7 million Australians could be using GLP-1s by 2036.
- Who
- Dr Kean-Seng Lim, a GP in western Sydney, is warning about risks from GLP-1 weight-loss drugs.
- What
- He says inadequate support can leave patients at risk of muscle loss, malnutrition, falls and weight regain.
- When
- The article was published on November 22, 2026. The patient’s treatment dates are not stated.
- Where
- A medical practice in Mount Druitt, western Sydney, Australia.
- Why
- Some patients use the drugs without follow-up or diet and exercise advice, and may not eat enough protein.
This story does not have two clearly opposing sides.
A woman over 60 took a GLP-1 drug prescribed by another provider without follow-up or diet and exercise advice.
The woman was found to have lost 10 kilograms of muscle mass and gained one kilogram of fat mass.
EY-Parthenon modelling published that month projected that up to 7 million Australians could use GLP-1s by 2036.
SMH published Dr Lim’s warning about the risks of using GLP-1 drugs without proper support.
- Patient’s muscle loss
- 10 kilograms
- Patient’s fat gain
- 1 kilogram
- Patient’s age
- Over 60
- Projected Australian GLP-1 users by 2036
- Up to 7 million people
- Article publication date
- November 22, 2026
What people are saying
They are powerful tools if used well, but they can be a double-edged sword
But worryingly, the focus for these agents has been on weight, rather than health
As with any powerful drug, we have got to use it properly. We need to be monitoring patients properly, ideally through a multidisciplinary team, because there are very real risks.
On further assessment using a body composition analysis, we found that she had lost 10 kilograms of muscle mass and gained one kilogram of fat mass, and she was now at quite a significant risk of falls